about
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteriaDetection of the floR gene in a diversity of florfenicol resistant Gram-negative bacilli from freshwater salmon farms in Chile.In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.Clinical and microbiological findings in prosthetic joint replacement due to aseptic loosening.Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values.Characterization of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis.Serotype, virulence profile, antimicrobial resistance and macrolide-resistance determinants in Streptococcus agalactiae isolates in pregnant women and neonates in Catalonia, Spain.Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative BacteriaMutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidisOzenoxacin: a review of preclinical and clinical efficacyComparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patientsThe Usefulness of Microalgae Compounds for Preventing Biofilm InfectionsMicrobiological profile of ozenoxacinNMR characterization and evaluation of antibacterial and antiobiofilm activity of organic extracts from stationary phase batch cultures of five marine microalgae (Dunaliella sp., D. salina, Chaetoceros calcitrans, C. gracilis and Tisochrysis lutea)Inhibition of Bacterial and Fungal Biofilm Formation by 675 Extracts from Microalgae and Cyanobacteria
P50
Q24596296-1B420B58-9E12-418B-A433-F7E36FD3BE6FQ39969882-997E90B9-FFAB-4641-9590-CC11CD571101Q41724574-47C61651-9CE7-47BA-9E9A-DE6F2883289BQ42213783-42C09ACE-141D-4B10-AD50-03028CC30F11Q44554680-7222688A-DADD-4513-A50F-5B965F6C586FQ44732755-E5FFBE54-C519-445B-B49C-62E255D525F5Q50065831-7D44133C-4783-43A1-BAA2-6A0C96C52762Q53684912-5A8E5D49-F61F-4F60-B319-DC7150F61ACEQ62769781-678926CE-B1D5-4958-92FC-4921862EEE64Q90611091-9DDDA88F-CC82-4507-B81D-72208AAF7A70Q91239953-11044BBE-EAFD-4F91-A761-9531EA22966FQ91773983-BF358279-DC0E-41C1-84A8-3DB7CD8F252DQ92258358-68E2C46C-91FF-4617-8A11-89EED83CA39BQ92320051-A25FD0CD-8E19-4892-9F3A-D8E3363732E1Q92587651-DF876DCD-DFC8-40E9-B4FA-2E874E512CA4Q92854466-23E6D286-03CE-450A-BE82-EBE05C1DFC1A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Y López
@en
Y López
@nl
type
label
Y López
@en
Y López
@nl
prefLabel
Y López
@en
Y López
@nl
P31
P496
0000-0001-7491-740X